학술논문
Cost-effectiveness analysis for PCV13 in adults 60 years and over with underlying medical conditions which put them at an elevated risk of pneumococcal disease in Japan.
Document Type
Article
Source
Expert Review of Vaccines; Sep2021, Vol. 20 Issue 9, p1153-1165, 13p
Subject
Language
ISSN
14760584
Abstract
Copyright of Expert Review of Vaccines is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)